lymphoma

(redirected from mantle cell lymphoma)
Also found in: Dictionary, Thesaurus, Medical, Acronyms, Wikipedia.

lymphoma,

a cancer of the tissue of the lymphatic systemlymphatic system
, network of vessels carrying lymph, or tissue-cleansing fluid, from the tissues into the veins of the circulatory system. The lymphatic system functions along with the circulatory system in absorbing nutrients from the small intestines.
..... Click the link for more information.
. There are two categories of lymphomas. One type is termed Hodgkin's diseaseHodgkin's disease,
a type of cancer of the lymphatic system. First identified in 1832 in England by Thomas Hodgkin, it is a type of malignant lymphoma. Incidence peaks in young adults and the elderly.
..... Click the link for more information.
, the other, non-Hodgkin's lymphoma (see lymphoma, non-Hodgkin'slymphoma, non-Hodgkin's,
any cancer of the lymphoid tissue (see lymphatic system) in which the Reed-Sternberg cells characteristic of Hodgkin's disease (the other category of lymphoma) are not present.
..... Click the link for more information.
). See also neoplasmneoplasm
or tumor,
tissue composed of cells that grow in an abnormal way. Normal tissue is growth-limited, i.e., cell reproduction is equal to cell death. Feedback controls limit cell division after a certain number of cells have developed, allowing for tissue repair
..... Click the link for more information.
.
The Columbia Electronic Encyclopedia™ Copyright © 2013, Columbia University Press. Licensed from Columbia University Press. All rights reserved. www.cc.columbia.edu/cu/cup/

lymphoma

[lim′fō·mə]
(medicine)
Any neoplasm, usually malignant, of the lymphoid tissues.
McGraw-Hill Dictionary of Scientific & Technical Terms, 6E, Copyright © 2003 by The McGraw-Hill Companies, Inc.
References in periodicals archive ?
If you are involved in the Global Mantle Cell Lymphoma Therapeutics industry or aim to be, then this study will provide you inclusive point of view.
How I treat mantle cell lymphoma. J Oncol Pract 2007 Sep;3(5):281-282.
Immunophenotypic variations in mantle cell lymphoma. Am J Clin Pathol.
Hagemeister, "Frequency of gastrointestinal involvement and its clinical significance in mantle cell lymphoma," Cancer, vol.
Current treatment standards and emerging strategies in mantle cell lymphoma. Hematology Am Soc Hematol Educ Program.
Campo, "Advances in the understanding of mantle cell lymphoma," British Journal of Haematology, vol.
This report provides comprehensive information on the therapeutic development for Mantle Cell Lymphoma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases.
Mantle cell lymphoma (MCL) is an aggressive small B-cell neoplasm that makes up about 2.5 percent to 7 percent of non-Hodgkin lymphoma (NHL).
Mantle cell lymphoma (MCL) is a lymphoproliferative disorder accounting for about 3-10% of all non-Hodgkin lymphomas [1].
Eight (42%) had follicular lymphoma, 6 (32%) had mantle cell lymphoma, 2 (11%) had diffuse large B-cell lymphoma, and 3 (16%) had chronic lymphocytic leukaemia.
The differential diagnosis based on histopathology includes follicular lymphoma, mantle cell lymphoma, B-CLL.
Mantle cell lymphoma (MCL) is an aggressive form of B-cell non-Hodgkin lymphoma.